Welcome to the new Independent website. We hope you enjoy it and we value your feedback. Please contact us here.


Market Report: Claims AstraZeneca has made $200-a-share offer for

AstraZeneca has joined the pharmaceutical sector’s M&A party, or so rumour has it. The British drug maker, which spent much of 2014 batting away interest from US heavyweight Pfizer, is said to have made a $200-a-share offer for Receptos, which values the San Diego-based firm at £4.1bn.

Market Report: Katherine Garrett-Cox in warning over shake-up

Having already seen off two investor revolts during her time as Alliance Trust’s chief executive, Katherine Garrett-Cox was forced to defend herself again yesterday by warning that the latest boardroom shake-up being planned by its largest shareholder “threatens the very existence of the company”.

Great start for our top share tips

The Indy's annual top 10 of stocks to pick have shown a 33 per cent return so far. James Moore, chief tipster, reflects on the gambles that seem to be paying off

Small Talk: Renewables group eyes higher profile with London listing

Another week, another listing – and this time investors can look forward to something different from the usual crop of oil & gas prospectors and mining plays. Australia's Wasabi Energy is already traded down under and this week, it will make its debut on AIM with a secondary listing as it seeks to raise its profile and broaden its investor base.

The Week Ahead: Time for boss of M&S to reveal his strategy

With recent reports that Marks and Spencer is looking to make a dramatic return to Europe, which it exited in 2001, all eyes are on the chief executive Marc Bolland, who has been in the top job for just over six months, to find out what he will reveal in his strategy presentation when the company posts its half-year results on Tuesday.

Small Talk: As with the country, in the oil business efficiency is all

The spectacle of the Chancellor, George Osborne, wielding his axe with such alacrity last week is setting an example for Tim Heeley, the newly-installed chief executive of the AIM-listed oil and gas explorer Nighthawk Energy. Nighthawk has had a tricky run, plagued by a steadily falling share price and uncontrolled rumour-mongering on internet bulletin boards. But when the two founders, David Bramhill and Joe O'Farrell, stepped down from the board last month, it was nothing to do with such troubles.

Small Talk: Confidence on Aim is rising despite fear of Coalition

George Osborne's axe is on its way and the doomsayers reckon that if applied too heavily, it could send the economy back into recession. But as reported in this column in recent months, the gloom appears to be lifting on the Alternative Investment Market (Aim). Several pieces of research have indicated that more companies are considering a listing or raising more money, and all the pointers show that confidence is on the up on the small-cap index.